In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company’s Code of Conduct to Regulate, Monitor and Report Trading in Securities by Insiders (referred to as the ‘Prohibition of Insider Trading Code’), Supriya Lifescience has informed that the Trading window for dealing in the Securities of the Company for all the Insiders, Designated Persons (including their immediate relatives), as defined in the Code, shall remain closed from January 01, 2024 till the expiry of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023. The date of the Board Meeting for consideration and approval of the Unaudited Financial results for the quarter and nine months ended December 31, 2023, shall be intimated separately in due course.
The above information is a part of company’s filings submitted to BSE.